Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c00537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Donghoon Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Hauptthemen laut MEDLINE: Cellular Senescence, Tumor Suppressor Protein p53, Apoptosis, Forkhead Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yuhan, Korea Basic Science Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Cellular senescence, marked by irreversible cell cycle arrest and senescence-associated secretory phenotype, contributes to aging and cancer recurrence. While chemotherapy can induce senescence in cancer cells, these therapy-induced senescent cells often resist apoptosis and promote tumor recurrence. The nuclear interaction between FOXO4 and p53 is crucial for senescent cell survival. Using NMR spectroscopy, we identified that hydrophobic interactions in the p53 transactivation domain play a key role in FOXO4 forkhead domain binding. Based on this structural information, we designed an optimized peptide inhibitor with reduced negative charges and incorporated a cationic cell-penetrating peptide for enhanced cellular delivery (CPP-CAND). CPP-CAND exhibited high selectivity for senescent cells, effectively disrupting nuclear FOXO4-p53 foci and inducing caspase-dependent apoptosis. Notably, it showed cytotoxicity against senescent cancer cells induced by different chemotherapeutic agents including doxorubicin and cisplatin. With its enhanced selectivity, l-amino acid composition, and shorter length, CPP-CAND represents a promising therapeutic candidate for targeting therapy-induced senescent cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
ORCID-Profile: Jaeseok Lee, Chin-Ju Park
Förderung
- Yuhan
- Korea Basic Science Institute
- National Research Foundation of Korea
Zitieren
APA
Kang, D., Lim, Y., Ahn, D., Lee, J., & Park, C. J. (2025). Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00537
Vancouver
Kang D, Lim Y, Ahn D, Lee J, Park CJ. Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00537
BibTeX
@article{Kang2025,
author = {Kang, Donghoon and Lim, Yeji and Ahn, Dabin and Lee, Jaeseok and Park, Chin-Ju},
title = {Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c00537}
}
EUVIMED